Pharmaceutical Asset Strategic Analysis: Bexicaserin
Strategy document design communicating a comprehensive asset-level strategic plan for a pharmaceutical development programme. The document structures complex clinical data, market analysis, and commercial strategy, translating technical research into executive-ready insights.
Client: Velocity Insights
Role: Information Designer
Timeline: 1 week